Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cinemark Holdings Inc CNK

Cinemark Holdings, Inc., is engaged in the motion picture exhibition business. The Company operates through two segments: United States markets and international markets. It operates 501 theatres and 5,719 screens in the United States, and Latin America. The Company’s United States circuit operated 309 theatres and 4,324 screens and its Latin America circuit operated 192 theatres and 1,395 screens across 13 countries. It also plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror, and action films. The Company offers various alternative entertainment content for its guests, which includes concert, sporting, and gaming events, as well as art, independent, faith-based, and multicultural foreign language films. In addition, it provides the functionality and technological infrastructure to live-stream events via satellite network across its portfolio of theatres in the United States and Latin America.


NYSE:CNK - Post by User

Post by whytestockson Aug 05, 2024 3:02pm
70 Views
Post# 36164896

Outperform Recommendation Issued On CNK By Macquarie

Outperform Recommendation Issued On CNK By Macquarie
JUST IN: $CNK Outperform Recommendation Issued On CNK By Macquarie2024-08-05 13:15:04 ET Macquarie analyst issues OUTPERFORM recommendation for CNK on August 5, 2024 11:55AM ET. The previous analyst recommendation was Outperform. CNK was trading at $25.145 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...CNK - Outperform Recommendation Issued On CNK By Macquarie

<< Previous
Bullboard Posts
Next >>